a) Gesellschaft mit beschränkter Haftung Gesellschaftsvertrag vom 26.03.2012 a) 14.05.2012 Merz b) Fall 1 2 b) Nicht mehr Geschäftsführer: de Wall, Udo, Mainz, *12.11.1963 Bestellt als Geschäftsführer: Dr. a) 10.07.2015 Zentgraf b) Fall 2 3 b) a) Abruf vom 30.04.2021 17:24 Handelsregister B des Amtsgerichts Frankfurt am Main Ausdruck Nummer der Firma: Seite 2 von 7 HRB 93737 Nummer der Eintragung a) Firma b) Sitz, Niederlassung, inländische Geschäftsanschrift, empfangsberechtigte Person, Zweigniederlassungen c) Gegenstand des Unternehmens Grund- oder Stammkapital a) Allgemeine Vertretungsregelung b) Vorstand, Leitungsorgan, geschäftsführende Direktoren, persönlich haftende Gesellschafter, Geschäftsführer, Vertretungsberechtigte und besondere Vertretungsbefugnis Prokura a) Rechtsform, Beginn, Satzung oder Gesellschaftsvertrag b) Sonstige Rechtsverhältnisse a) Tag der Eintragung b) Bemerkungen 1 2 3 4 5 6 7 Nicht mehr Geschäftsführer: Dr. a) Die Gesellschafterversammlung vom 28.06.2019 hat die Neufassung des Gesellschaftsvertrages, insbesondere die Änderung in den §§ 1.1 (Firma) und 2 (Gegenstand des Unternehmens) beschlossen.

Microsoft PowerPoint - AVNT June IR Conferences_6.1.2023 1130AM AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) J U N E 2 0 2 3 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. vehicles to be 100% electric by 2032 Where Avient Wins:  Lightweight panels that establish both strength and stiffness resulting in decreased energy usage, lower emissions  Long-lasting Color applications to resist UV exposure, temperature fluctuations and exceed the stylistic requirements of global automakers 19 $130 $530 Q2 FY $0.60 $2.40 Q2 FY 2023 GUIDANCE 20 Sales Adjusted EBITDA $845 $3,400 Q2 FY Adjusted EPS (in millions) (in millions) CA SH FLOW / LEV ER AGE 21 • Maintaining free cash flow and leverage guidance from February earnings call • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x LONG-TERM REVENUE GROWTH DRI VERS Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Healthcare 8–10% Composites 10% Asia / LATAM 5% Other (GDP growth) 2–3% Avient 6.5% 22 Sustainable Solutions 32% Asia / LATAM 15% Composites 8% Healthcare 6% Other (GDP Growth) 39% • Virtual presentation to be held 2023年9月20日 • The company will be conducting an investor-focused presentation around our sustainability solutions portfolio Avient Confidential 23 SUSTAINABILITY INVESTOR DAY 23 $340M $405M $455M $550M $790M $915M 2016 2017 2018 2019 2020PF** 2021 2022PF*** SUSTA INAB ILITY F OR A BETTER TOMOR ROW Revenue From Sustainable Solutions* 2016-2022 ($ in millions) Organic Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 24 *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business ***2022 is Pro Forma for the acquisition of Avient Protective Materials and the divestiture of Distribution $1,175M Lightweighting Eco-Conscious Recycle Solutions VOC Reduction Sustainable Infrastructure Human Health & Safety Reduced Energy Use Bio-polymers SUSTA INAB ILITY NEEDS BY M ARKET B&C • Eco-Conscious • Carbon footprint • Resource conservation Healthcare • Carbon footprint • Bio based content • Eco-Conscious Automotive • Light weighting • Recycled Content • VOC reduction Consumer • Recycle Solutions • Light weighting • Carbon Footprint Packaging • Recycle Solutions • Light weighting • Food waste reduction Common Theme: CO2 Emission Goals Increasing Single-Use Plastic Regulation 25 I NV ESTI NG I N INNOVATI ON S U S T A I N A B I L I T Y P O R T F O L I O 26 A P P E N D I X 29 RAW MATERIAL 2022 ANNUAL PURCHASES Performance Additives 16% Pigments 12% TiO2 10% Dyestuffs 2% Polyethylene 11% Nylon 6% Polypropylene 5% Styrenic Block Copolymer 5% Other Raw Materials 33% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials • Cost inflation decelerating, particularly for hydrocarbon-based raw materials 2022 pro forma results for the acquisition of Avient Protective Materials SEGMENT DATA U.S. & Canada 40% EMEA 37% Asia 18% Latin America 5% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 20% Packaging 24% Industrial 15% Building and Construction 10% Telecommunications 4% Energy 4% Defense 6% END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) Transportation 9% Healthcare 8% 31 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs C O L O R , A D D I T I V E S & I N K S 2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N US & Canada 34% EMEA 38% Asia 20% Latin America 8% END MARKET REGION 32 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 2% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S 2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N END MARKET US & Canada 52% EMEA 35% Asia 13% REGION 33 Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 32% Consumer 27% Healthcare 8% Industrial 14% Building & Construction 5% Telecommunications 3% Energy 1% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S B Y E N D M A R K E T Packaging 27% Consumer 14% Healthcare 5% Industrial 17% Building & Construction 10% Energy 5% Defense 8% EMEA (37% of sales)Transportation 11% Packaging 13% Consumer 24% Healthcare 12% Industrial 15% Building & Construction 13% Energy 5% Defense 5% US & Canada (40% of sales) Transportation 7% Packaging 56% Consumer 23% Healthcare 4% Industrial 7% Building & Construction 4% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3% Telecommunications 6% 34 PEER COMPARISONS AV I E N T I S A S SE T L I G H T Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of 2023年5月31日 Note: Avient reflects 2023 estimated revenue of $3,400 and estimated run-rate CAPEX of $110M. 36 3 2 3 3 4 4 3 3 4 5 5 6 8 9 A vi e n t K W R P P G F U L A V Y R P M F M C H U N C E H X L E C L A S H E M N S C L F R E E C A S H F LOW C O N V E R S I O N Source: Peer data per Bloomberg as of 2023年5月31日 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 38 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.6 13.2 13.0 12.8 11.3 8.6 17.9 16.8 10.7 8.8 8.8 8.7 7.5 6.9 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 8 ) A vi e n t (2 0 2 3 ) K W R P P G R P M A V Y F U L E C L H X L F M C S C L C E A S H E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Microsoft PowerPoint - AVNT Q3 2022 Earnings Presentation AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 2 R E S U L T S (NYSE: AVNT) N O V E M B E R 2 , 2 0 2 2 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EBITDA Margins (1) • Focus on organic growth combined with transformative and bolt-on acquisitions • Divested commodity businesses tied to more cyclical end markets • Expanded presence in high growth areas of sustainable solutions, specialty healthcare applications, composites and more resilient end markets 5.4% 11.5% 16.1% 2006 2018 2022PF $142 $408 $585 2006 2018 2022PF 2006 figures exclude joint venture results 14 RETURNING CASH TO SHAREHOLDERS Growing Dividend 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 22 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 0.99 11 12 13 14 15 16 17 18 19 20 21 22 23 ~$1Bn REPURCHASED OVER LAST 11 YEARS ~$550MM PAID OVER LAST 11 YEARS Dividends Share Repurchases Cumulative Buybacks $ B n $ p e r sh a re $2.95 2022 PRO FORMA ADJUSTED EPS Earnings Growth Expanding Profitability $0.15 $1.09 $2.08 $2.67 $2.95 2009 2012 2015 2018 2022PF T H I R D Q U A R T E R 2 0 2 2 R E S U L T S $110 $119 2021 2022 $0.61 $0.59 2021 2022 Q3 2022 PERFORMANCE ( T O TA L C O M PA N Y C O N T. Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 23 C O L O R , A D D I T I V E S & I N K S 2 0 2 2 R E V E N U E | $ 2 . 3 B I L L I O N US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 24 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A L T Y E N G I N E E R E D M A T E R I A L S 2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 25 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S B Y E N D M A R K E T Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3% Telecommunications 6% Figures represent 2022 full year estimates Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Müller, CEO SQS 41 7 0 _ 2 / J u n e 2 0 19 / V er si o n 2 .0 A.

Müller, CEO SQS 6 67 0 _ 2 / J u n e 2 0 19 / V er si o n 2 .0 A.

NYSE: AVNT) AVIE NT CORP ORAT ION S P E C I A L T Y P O R T F O L I O T R A N S F O R M A T I O N C O N T I N U E S W I T H D Y N E E M A A C Q U I S I T I O N 2 0 2 2 F I R S T Q U A R T E R R E S U L T S D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. F I R S T Q U A R T E R 2 0 2 2 R E S U L T S $123 $136 2021 2022 $0.89 $0.99 2021 2022 Q1 2022 PERFORMANCE ( T O TA L C O M PA N Y ) 4 $1,162 $1,294 2021 2022 + 11% (+ 14% excluding FX) Adjusted EPS + 11% (+ 15% excluding FX) + 11% (+ 16% excluding FX) (in millions) (in millions) Sales Adjusted Operating Income Q1 2022 SEGMENT PERFORMANCE 5 CAI $609 $650 Sales ($ in millions) SEM Distribution $89 $95 Operating Income + 7% (+ 10% excluding FX) $363 $433 Sales $24 $24 Operating Income + 19% Flat (1) $217 $245 Sales $34 $40 Operating Income + 7% (+ 11% excluding FX) + 13% (+ 17% excluding FX) + 18% (+ 20% excluding FX) Q1 2021 $1,162 $123 Sustainable Solutions 19 8% 7 Healthcare 32 21% 6 Composites (excl. Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) Financial information is pro forma to include a full year of Clariant Color acquisition ($ in millions) 11.9% 16.2% 2019PF 2021 EBITDA Margins (1) S P E C I A LT Y T R A N S F O R M AT I O N 7% 46% 66% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2021 2022 PF % o f A dj us te d E B IT D A (1 ) JVs Distribution Performance Products & Solutions Specialty (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution (2) 29 12% 18% 16% 15% 15% 14% 14% 28% 28% 26% 25% 22% 21% 19% 16% 12% 9% 9% A vi en t T od ay A vi en t P F A V Y P P G K W R FU L R P M C E A LB FM C A S H E C L E M N H X L H U N S C L B N R U N V R Median: 21%Median: 15% 2 0 2 2 E B I T DA M A RG I N S V S .

Attachment 2 Tax adjustments(2) 2)

Microsoft PowerPoint - Avient IR Presentation - May 2021 AVIENT CORPORATION M A Y 2 0 2 1 I N V E S T O R M E E T I N G S (NYSE: AVNT) D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Reduce Scope 1 & 2 greenhouse gas emissions by 35%. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 26 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 4 3 3 3 4 4 5 5 5 6 7 7 8 24 A vi e n t A vi e n t (E xc l.

Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) F E B R U A R Y 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE AND RE COGNIT ION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- F E B R U A R Y 1 4 , 2 0 2 4 W E B C A S T P R E S E N T AT I O N DR. PY ( T O TA L C O M PA N Y ) $790 $719 2022 2023 $107 $114 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.52 2022 2023 Adjusted EPS (in millions) - 9% + 7% + 24% Sales Adjusted EBITDA Adjusted EPS 15 Q4 2023 SEGMENT PERFORMANCE 16 CAI $491 $459 Sales (in millions) $70 $84 EBITDA SEM $301 $260 Sales $55 $49 EBITDA - 7% - 14%+20% - 11% 2022 2023 (in millions) Q4 EBITDA BRIDGE ( T O TA L C O M PA N Y ) 17 $ millions CAI: Price / Mix 11 Deflation 14 SEM: Price / Mix 4 Deflation 9 Net Price Benefit 38 Cost Reductions 13 Wage Inflation (8) Other (2) Q4 2023 $114 Adjusted EBITDA Q4 2022 $ 107 Demand (34) • Demand was down, but less than in previous quarters, due to slowing pace of destocking • Positive net price benefit: o CAI – Pricing flat with favorable mix from uptick in packaging and consumer end markets and raw material deflation o SEM - Pricing flat with favorable mix from Composites and raw material deflation • Cost reductions primarily driven by reduced administrative costs and cost synergies 2 0 2 4 G U I D A N C E 2024 GUIDANCE Full Year 2024 Guidance Adjusted EBITDA $505 to $535 million Adjusted EPS $2.40 to $2.65 Interest Expense $105 to $110 million Adjusted Effective Tax Rate 23% to 25% Capital Expenditures ~$140 million 19 Q1 Adjusted EPS of $0.68 A P P E N D I X 21 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RA W MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 23 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 24 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 25 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 3 AV I E N T R E G I O N A L S A L E S Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 26 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Microsoft PowerPoint - Investing in Avient - V17 - the MASTER AVIENT CORPORATION (NYSE: AVNT) O C T O B E R 2 0 2 0 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. PEER COMPARISONS 16 2 3 2 3 3 3 6 3 4 4 4 4 5 5 6 6 7 8 9 23 A vi e n t A vi e n t (E xc l. SEGMENT HIGHLIGHTS Packaging 37% Consumer 22% Healthcare 8% Industrial 14% Building & Construction 8% Transportation 6% Wire & Cable 3% Electrical & Electronics 2% C O L O R , A D D I T I V E S & I N K S 2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N $9 $310 2.0% 15.5% 2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business US & Canada 32% Europe 39% Asia 23% Latin America 6% END MARKET REGION EBITDA DOLLAR & MARGIN EXPANSION 24 US & Canada 59% Europe 23% Asia 18% Consumer 23% Healthcare 10% Packaging 6% Wire & Cable(1) 25% Electrical & Electronics 14% Industrial 10% Transportation 10% Building & Construction 2% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S 2 0 2 0 E R E V E N U E | $ 6 8 5 M I L L I O N 0.9% 16.8% END MARKET REGION EBITDA DOLLAR & MARGIN EXPANSION 25 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling Healthcare 30% Consumer 24%Packaging 3% Industrial 19% Transportation 15% Electrical & Electronics 4% Building & Construction 4% Wire & Cable 1% US & Canada 79% Asia 2% Latin America 19% END MARKET REGION EBITDA DOLLAR & MARGIN EXPANSION D I S T R I B U T I O N 2 0 2 0 E R E V E N U E | $ 1 . 0 5 B I L L I O N $20 $65 2.9% 6.2% K E Y S U P P L I E R S 26 AMERICAS EUROPE ASIA Consumer 26% Healthcare 19% Packaging 13% Industrial 16% Wire & Cable 7% Building & Construction 5% Electrical & Electronics 4% Packaging 35% Consumer 14%Healthcare 6% Industrial 17% Wire & Cable 10% Building & Construction 8% Electrical & Electronics 3% Packaging 32% Consumer 26% Healthcare 12% Industrial 7% Wire & Cable 6% Building & Construction 4% Electrical & Electronics 9% Transportation 10% Transportation 7% Transportation 4% 2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business T O T A L C O M PA N Y R E G I O N A L S A L E S B Y E N D M A R K E T (58% of sales) (25% of sales) (17% of sales) 27